Skip to NavigationSkip to content

News

0
Janssen has spoken out against plans to use an anaesthetic drug it invented over 50 years ago to execute prisoners, adding its voice to many others...
0
Cancer Research UK has announced that its collaboration with Eli Lilly for the treatment of advanced solid tumours will progress to the clinic, with...
0
Researchers from The Institute of Cancer Research have potentially found a new use for Imbruvica, after discovering a weakness in certain types of...
0
Novartis has launched what it claims is the first large-scale mobile research study which will gather data on multiple sclerosis (MS) from patients...

Features

Owen Marks, Country Head for the Rare Disease Unit at Pfizer UK, discusses his career so far and what drives his work in rare diseases.